Arbor Biotechnologies: Funding, Investors & Team (Sep 2026)
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
Arbor Biotechnologies has raised $289M across 2 funding rounds on record, the most recent a Series C of $73.9M announced in Mar 2025.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Arbor Biotechnologies Company Profile and Key Stats
Latest funding round on record: Mar 2025.
Arbor Biotechnologies Funding Rounds
Arbor Biotechnologies raised $215M in a Series B announced in Nov 2021.
3.3 years later, a Series C of $73.9M was announced in Mar 2025.
Arbor Biotechnologies Founders and Leadership Team
Contact details for the Arbor Biotechnologies team: 2 of 2 have an email address on file.
Start 14-day free trial →Arbor Biotechnologies Funding Compared to Other Biotechnology Startups
Arbor Biotechnologies' latest round of $73.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Arbor Biotechnologies in Biotechnology and Cambridge
Companies Similar to Arbor Biotechnologies
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Arbor Biotechnologies Funding FAQs
What does Arbor Biotechnologies do?
Arbor Biotechnologies is an operator of a bio-discovery company intended to provide human diagnostic development services. The company's platform employs a diverse set of technologies and techniques including artificial intelligence, genome sequencing, gene synthesis, and high-throughput screening, enabling drug developers to accelerate the discovery of proteins for improving human health and sustainability.
How much funding has Arbor Biotechnologies raised?
Arbor Biotechnologies has raised $289M across 2 rounds on record. The most recent is a Series C of $73.9M announced in Mar 2025.
When did Arbor Biotechnologies last raise funding?
Arbor Biotechnologies' most recent funding round on record is a Series C of $73.9M, announced in Mar 2025.
Who founded Arbor Biotechnologies?
FundedIQ lists David R Walt (Founder) at Arbor Biotechnologies.
Who is the CEO of Arbor Biotechnologies?
Winston Yan is listed as CEO at Arbor Biotechnologies.
Where is Arbor Biotechnologies headquartered?
Arbor Biotechnologies is based in Cambridge, Massachusetts, United States.
How many employees does Arbor Biotechnologies have?
Arbor Biotechnologies is in the 51-100 employee band.
How does Arbor Biotechnologies' funding compare to other Biotechnology startups?
Arbor Biotechnologies' latest round of $73.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,182 tracked companies over the last two years.
About FundedIQ's Arbor Biotechnologies Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Arbor Biotechnologies is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.